evrazkarЕвразийский Кардиологический ЖурналEurasian heart journal2225-16852305-0748Евразийская ассоциация кардиологов10.38109/2225-1685-2012-2-6-15evrazkar-5448Research ArticleОРИГИНАЛЬНЫЕ СТАТЬИORIGINAL PAPERSДИАГНОСТИКА И ЛЕЧЕНИЕ ОТЕКА ЛЕГКИХDYAGNOSIS AND TREATMENT OF CARDIAC PULMONARY OEDEMAТерещенкоС. Н.TereschenkoS. N.stereschenko@yandex.ruЖировИ. В.ZhirovI. V.noemail@neicon.ruНаконечниковС. Н.NakonechnikovS. N.snn_cardio@mail.ruНИИ кардиологии им А. Л. Мясникова ФБГУ РКНПК Минздрава РФРоссияRussian cardiology research and clinical complex, Ministry of health of the Russian FederationRussian Federation20123006201202615Copyright © Терещенко С.Н., Жиров И.В., Наконечников С.Н., 20122012Терещенко С.Н., Жиров И.В., Наконечников С.Н.Tereschenko S.N., Zhirov I.V., Nakonechnikov S.N.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.heartj.asia/jour/article/view/5448

Представлены современные сведения о патогенезе, диагностике и лечебных стратегиях у пациентов с кардиогенным отеком легких. В табличной форме изложен дифференциальный диагноз, приведены алгоритмы медикаментозной и респираторной поддержки.

In this review are outlined key points of pathogenesis, differential diagnosis and treatment strategy in cardiac pulmonary oedema. Are included table data of medical and respiratory assistance?

кардиогенный отек легкихинотропные средствавазодилататорынеинвазивная вентиляция легкихpulmonary oedemainotropic drugsvasodilatorsnon-invasive ventilationReferencesSwedberg К., Nieminen M.S., Cleland J., et all. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005). The task force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology. Eur Heart J 26: 1115-1140Swedberg К., Nieminen M.S., Cleland J., et all. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005). The task force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology. Eur Heart J 26: 1115-1140Mariell Jessup, M.D., and Susan Brozena, M.D. Heart Failure NEJM 2003, N 20, Volume 348: 2007-2018.Mariell Jessup, M.D., and Susan Brozena, M.D. Heart Failure NEJM 2003, N 20, Volume 348: 2007-2018.Alla F., Zannad F., Filippatos G. Epidemiology of acute heart failure syndromes at Heart Fail Rev. 2007 Jun; 12(2): 91-5.Alla F., Zannad F., Filippatos G. Epidemiology of acute heart failure syndromes at Heart Fail Rev. 2007 Jun; 12(2): 91-5.Konstam M.A. Progress in heart failure management? Lessons from the real world. Circulation 2000; 102: 1076-1078.Konstam M.A. Progress in heart failure management? Lessons from the real world. Circulation 2000; 102: 1076-1078.Cleland J.G., Swedberg K., Follath F. et al. The EuroHeart Failure survey programme-a survey on the quality of care among patients with heart failure in Europe. Part 1: Patient characteristics and diagnosis. Eur Heart J 2003; 24: 442-463.;Cleland J.G., Swedberg K., Follath F. et al. The EuroHeart Failure survey programme-a survey on the quality of care among patients with heart failure in Europe. Part 1: Patient characteristics and diagnosis. Eur Heart J 2003; 24: 442-463.;Fox K.F., Cowie M.R., Wood D.A. et al. Coronary artery disease as the cause of incident heart failure in the population. Eur Heart J 2001; 22: 228-236.;Fox K.F., Cowie M.R., Wood D.A. et al. Coronary artery disease as the cause of incident heart failure in the population. Eur Heart J 2001; 22: 228-236.;ATKhadra A.S., Salem D.N., Rand W.M. et al. Warfarin anticoagulation and survival: a cohort analysis from the studies of left ventricular dysfunction. J Am Coll Cardiol 1998; 31: 749-753ATKhadra A.S., Salem D.N., Rand W.M. et al. Warfarin anticoagulation and survival: a cohort analysis from the studies of left ventricular dysfunction. J Am Coll Cardiol 1998; 31: 749-753Mosesso V. N., Dunford J., Blackwel T., Griswell J. K. Prehospital therapy for acute congestive heart failure: state of the art. Prehospital Emergency Care January 2003; 7: 13-23Mosesso V. N., Dunford J., Blackwel T., Griswell J. K. Prehospital therapy for acute congestive heart failure: state of the art. Prehospital Emergency Care January 2003; 7: 13-23Nieminen M.S., D. Brutsaert, K. Dickstein at all. EuroHeart Failure Survey II): a survey on hospitalized acute heart failure patients: description of population European Heart Journal Vol. 27, N 22 Pp. 2725-2736 2006Nieminen M.S., D. Brutsaert, K. Dickstein at all. EuroHeart Failure Survey II): a survey on hospitalized acute heart failure patients: description of population European Heart Journal Vol. 27, N 22 Pp. 2725-2736 2006Cotter G., Kaluski E., Moshkovitz Y., Milovanov O., Krakover R., Vered Z. Pulmonary edema: new insight on pathogenesis and treatment. Curr Opin Cardiol. 2001; 16: 159-63.Cotter G., Kaluski E., Moshkovitz Y., Milovanov O., Krakover R., Vered Z. Pulmonary edema: new insight on pathogenesis and treatment. Curr Opin Cardiol. 2001; 16: 159-63.Mitchell J.E., Palta S. New diagnostic modalities in the diagnosis of heart failure. // J Natl Med Assoc. - 2004 Nov. -№ 6(11). - p. 1424-30.Mitchell J.E., Palta S. New diagnostic modalities in the diagnosis of heart failure. // J Natl Med Assoc. - 2004 Nov. -№ 6(11). - p. 1424-30.Berger R., Huelsman M., Strecker K., et al. В-type natriuretic peptide predicts sudden death in patients with chronic heart failure. // Circulation. -2002. - № 105. - p.2392-2397Berger R., Huelsman M., Strecker K., et al. В-type natriuretic peptide predicts sudden death in patients with chronic heart failure. // Circulation. -2002. - № 105. - p.2392-2397Torbjorn Omlandt Heart failure in the emergency department*: Is В-type natriuretic peptide a better prognostic indicator than clinical assessment?. // Journal of the American College of Cardiology. - September 2004. - Volume 44. - Issue 6, 15. - p. 1334-1336Torbjorn Omlandt Heart failure in the emergency department*: Is В-type natriuretic peptide a better prognostic indicator than clinical assessment?. // Journal of the American College of Cardiology. - September 2004. - Volume 44. - Issue 6, 15. - p. 1334-1336Muders F., Kromer E.P., Griese D.P., et al. Evaluation of plasma natriuretic peptides as markers for left ventricular dysfunction. // Am Heart J. - 1997. - № 134. - p. 442-449.Muders F., Kromer E.P., Griese D.P., et al. Evaluation of plasma natriuretic peptides as markers for left ventricular dysfunction. // Am Heart J. - 1997. - № 134. - p. 442-449.Maeda K., Takayoshi T., Wada A., et al. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. // Am Heart J. - 1998. - № 135. - p. 825-832.Maeda K., Takayoshi T., Wada A., et al. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. // Am Heart J. - 1998. - № 135. - p. 825-832.Aberle D.R., Wiener-Kronish J.P., Webb W.R., Matthay M.A. Hydrostatic versus increased permeability pulmonary edema: diagnosis based on radiographic criteria in critically ill patients. Radiology 1988; 168: 73-9.Aberle D.R., Wiener-Kronish J.P., Webb W.R., Matthay M.A. Hydrostatic versus increased permeability pulmonary edema: diagnosis based on radiographic criteria in critically ill patients. Radiology 1988; 168: 73-9.Duane P.G., Colice G.L. Impact of noninvasive studies to distinguish volume overload from ARDS in acutely ill patients with pulmonary edema: analysis of the medical literature from 1966 to 1998. Chest 2000; 118: 1709-17.Duane P.G., Colice G.L. Impact of noninvasive studies to distinguish volume overload from ARDS in acutely ill patients with pulmonary edema: analysis of the medical literature from 1966 to 1998. Chest 2000; 118: 1709-17.Lorraine B. Ware, M.D., and Michael A. Matthay, M.D. Acute Pulmonary Edema NEJM 2005 N 26Volume 353: 2788-2796Lorraine B. Ware, M.D., and Michael A. Matthay, M.D. Acute Pulmonary Edema NEJM 2005 N 26Volume 353: 2788-2796Swan H.J., Ganz W., Forrester J., Marcus H., Diamond G., Chonette D. Catheterization of the heart in man with use of a flow-directed balloon-tipped catheter. N Engl J Med 1970; 283: 447-51.Swan H.J., Ganz W., Forrester J., Marcus H., Diamond G., Chonette D. Catheterization of the heart in man with use of a flow-directed balloon-tipped catheter. N Engl J Med 1970; 283: 447-51.Masip J., Betbese A.J., Paez J. et al. Non-invasive pressure support ventilation versus conventional oxygen therapy in acute cardiogenic pulmonary oedema: a randomised trial. Lancet 2000; 356: 2126-2132.Masip J., Betbese A.J., Paez J. et al. Non-invasive pressure support ventilation versus conventional oxygen therapy in acute cardiogenic pulmonary oedema: a randomised trial. Lancet 2000; 356: 2126-2132.Sharon A., Shpirer I., Kaluski E. et al. High-dose intravenous isosorbide-dinitrate is safer and better than Bi-PAPventilation combined with conventional treatment for severe pulmonary edema. J. Am Coll Cardiol 2000; 36: 832-837.Sharon A., Shpirer I., Kaluski E. et al. High-dose intravenous isosorbide-dinitrate is safer and better than Bi-PAPventilation combined with conventional treatment for severe pulmonary edema. J. Am Coll Cardiol 2000; 36: 832-837.Brater D.C. Resistance to loop diuretics. Why it happens and what to do about it. Drugs 1985; 30: 427-443Brater D.C. Resistance to loop diuretics. Why it happens and what to do about it. Drugs 1985; 30: 427-443Kramer W.G., Smith W.B., Ferguson J. et al. Pharmacodynamics of torsemide administered as an intravenous injection and as a continuous infusion to patients with congestive heart failure. J. Clin Pharmacol 1996; 36: 265-270.Kramer W.G., Smith W.B., Ferguson J. et al. Pharmacodynamics of torsemide administered as an intravenous injection and as a continuous infusion to patients with congestive heart failure. J. Clin Pharmacol 1996; 36: 265-270.Channer K.S., McLean K.A., Lawson-Matthew P. et al. Combination diuretic treatment in severe heart failure: a randomised controlled trial. Br Heart J. 1994; 71: 146-150.Channer K.S., McLean K.A., Lawson-Matthew P. et al. Combination diuretic treatment in severe heart failure: a randomised controlled trial. Br Heart J. 1994; 71: 146-150.Cotter G., Metzkor E., Kaluski E. et al. Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema. Lancet 1998; 351: 389-393.Cotter G., Metzkor E., Kaluski E. et al. Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema. Lancet 1998; 351: 389-393.Cotter G., Weissgarten J., Metzkor E. et al. Increased toxicity of highdose furosemide versus low-dose dopamine in the treatment of refractory congestive heart failure. Clin Pharmacol Ther 1997; 62: 187-193.Cotter G., Weissgarten J., Metzkor E. et al. Increased toxicity of highdose furosemide versus low-dose dopamine in the treatment of refractory congestive heart failure. Clin Pharmacol Ther 1997; 62: 187-193.Katz A.M. Potential deleterious effects of inotropic agents in the therapy of chronic heart failure. Circulation 1986; 73: lll 184-11190Katz A.M. Potential deleterious effects of inotropic agents in the therapy of chronic heart failure. Circulation 1986; 73: lll 184-11190Kivikko M., Lehtonen L., Colucci W.S. Sustained hemodynamic effects of intravenous levosimendan. Circulation 2003; 107: 81-86.Kivikko M., Lehtonen L., Colucci W.S. Sustained hemodynamic effects of intravenous levosimendan. Circulation 2003; 107: 81-86.Innes C.A., Wagstaff A.J. Levosimendan: A review of its use in the management of acute decompensated heart failure. Drugs 2003,63: 2651-2671.Innes C.A., Wagstaff A.J. Levosimendan: A review of its use in the management of acute decompensated heart failure. Drugs 2003,63: 2651-2671.Follath F., Cleland J.G., Just H. et al. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet 2002; 360: 196-202.Follath F., Cleland J.G., Just H. et al. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet 2002; 360: 196-202.Slawsky M.T., Colucci W.S., Gottlieb S.S. et al. Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure. Study Investigators. Circulation 2000; 102: 2222-2227.Slawsky M.T., Colucci W.S., Gottlieb S.S. et al. Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure. Study Investigators. Circulation 2000; 102: 2222-2227.

The authors declare that there are no conflicts of interest present.